Ontology highlight
ABSTRACT: Background
Diabetic foot infections (DFIs) are a frequent complication of Diabetes mellitus and a major cause of nontraumatic limb amputations. The Gram-positive bacterium Staphylococcus aureus, known for its resilient biofilms and antibiotic resistant profile, is the most frequent DFI pathogen. It is urgent to develop innovative treatments for these infections, being the antimicrobial peptide (AMP) nisin a potential candidate. We have previously proposed the use of a guar gum biogel as a delivery system for nisin. Here, we evaluated the potential of the nisin-biogel to enhance the efficacy of conventional antibiotics and antiseptics against DFIs S. aureus clinical isolates.Methods
A collection of 23 S. aureus strains isolated from DFI patients, including multidrug- and met
SUBMITTER: Santos R
PROVIDER: S-EPMC6655664 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature